Effects of Sleep, Fatigue, and Timing of Post-dates Inductions Among Nulliparas

NCT ID: NCT01542151

Last Updated: 2015-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized clinical trial will examine if there are any differences between post-dates inductions (inductions after 40 weeks of pregnancy) begun in the morning compared to the evening for first-time mothers. Sleep and fatigue measures will be measured to see if they differ by time of induction. Other measures will include the rate of births within 24 hours of admission, length of labor, use of labor analgesics, and method of delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Randomized clinical trial of first-time pregnant women requiring post-dates induction (induction after 40 weeks gestation). Women will be randomized to a labor induction time in the morning or the evening. On hospital admission once women have signed the study consent, they will complete sleep questionnaires and a fatigue assessment. Fatigue and sleep time assessments will subsequently done by the study subject every 4 hours until women enter active labor. At the onset of active labor, assessments will stop. Labor outcomes and patient satisfaction will be obtained once women deliver.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy, Prolonged

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Morning

Women randomized to a labor induction in the morning between 0600 and 1000.

Group Type ACTIVE_COMPARATOR

Time of labor induction

Intervention Type OTHER

Assigned time of labor induction - morning or evening

Evening

Women randomized to a labor induction begun in the evening between 1700-2100

Group Type EXPERIMENTAL

Time of labor induction

Intervention Type OTHER

Assigned time of labor induction - morning or evening

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Time of labor induction

Assigned time of labor induction - morning or evening

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Labor, induced

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant at 40 weeks gestation or more
* Nulliparous
* 14 years old or older
* English or Spanish speaking
* Healthy maternal status
* Labor induction able to be scheduled

Exclusion Criteria

* Less than 40 weeks gestation
* Multiparous
* Younger than 14 years old
* Not able to speak or write in English or Spanish
* Fetal or maternal status requires immediate induction
Minimum Eligible Age

14 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, San Francisco

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary K Barger, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Clifornia, San Francisco

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Community Medicall Center

Fresno, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TimeIOL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.